HOME >> MEDICINE >> NEWS
Research Offers New Tool In Fight Against Prostate Cancer

ANN ARBOR---Research from the University of Michigan Comprehensive Cancer Center strongly suggests that PSA tests can reliably gauge the effectiveness of chemotherapy for advanced prostate cancer.

A reliable method of assessing a cancer patient's response to treatment is important. It shows doctors whether the prescribed therapy is working and allows them to quickly and confidently change the treatment plan when it's ineffective---and presumably improve the patient's quality of life as a result.

The U-M researchers studied 62 men with advanced prostate cancer and found that those whose PSA level declined 50 percent or more after eight weeks of chemotherapy had a significantly higher survival rate.

PSA screening tests are used to measure the level of a prostate-specific antigen in the blood---which indicates the presence of prostate cancer. They also have been used to gauge patients' response to cancer therapy, but that application has been controversial because opinions differ on its validity and precisely how to interpret test results.

The U-M researchers found that patients whose PSA levels declined at least 50 percent after eight weeks of chemotherapy survived for 91 weeks (median), compared with 38 weeks for those whose PSA level did not decline 50 percent.

The study is detailed in the May issue of the Journal of Clinical Oncology. It was conducted by David C. Smith, M.D.; Kenneth J. Pienta, M.D.; Rodney L. Dunn, M.S.; and Myla S. Strawderman, M.S.


'"/>

Contact: David Wilkins
wilkins@umich.edu
(734) 764-2220
University of Michigan
30-Apr-1998


Page: 1

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Research offers hope of new treatments for liver damage
3. Research suggests possible blood test for multiple sclerosis
4. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
5. 2005 Award for Basic Research in Biological Mineralization
6. 2005 Craniofacial Biology Research Award
7. 2005 Research in Dental Caries Award
8. 2005 Research in Prosthodontics and Implants Award
9. 2005 Basic Research in Periodontal Disease Award
10. 2005 Research in Oral Biology Award
11. 2005 Pulp Biology Research Award

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Research Offers New Tool Fight Against Prostate Cancer

(Date:9/2/2015)... ... September 02, 2015 , ... A ... is taking action after seeing a significant increase in unlawful tactics used by ... has found many cases of OON ASCs encouraging members to have elective procedures ...
(Date:9/2/2015)... Chicago, IL (PRWEB) , ... September 02, 2015 ... ... engineer of patented products, announces Hand Free Pocket Cop, a safety invention that ... in the US is worth $31 billion," says Scott Cooper, CEO and Creative ...
(Date:9/2/2015)... ... ... On September 9, 2015, over 27,000 people from all over the world ... date for the state of Utah. , “We are thrilled with the overwhelming response ... doTERRA CEO. “One of the most exciting elements of our convention is the opportunity ...
(Date:9/2/2015)... ... September 02, 2015 , ... Please ... Aneurysm Awareness Month , which was established by the Foundation in 2007 with ... education, and helping fund more research remains our top priority,” commented Christine Buckley, ...
(Date:9/2/2015)... , ... September 02, 2015 , ... Mobile working is ... the go. It seems that everywhere new mobile apps are being launched, and mobile ... to as a regular part of their work and personal lives. What's more people ...
Breaking Medicine News(10 mins):Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7Health News:doTERRA to Host the Largest Single-Company Convention in the State of Utah 2Health News:September Celebrated as Brain Aneurysm Awareness Month 2Health News:New Mobility Experience From Winscribe 2Health News:New Mobility Experience From Winscribe 3
(Date:9/2/2015)... 2015 CytoSorbents Corporation (NASDAQ: CTSO ), ... blood purification technology to reduce deadly uncontrolled inflammation ... Dr. Phillip Chan , MD, PhD, will present ... (sponsored by H.C. Wainwright & Co) taking ... City.  Currently, the management team will ...
(Date:9/2/2015)... 2, 2015   Voalte , the leader in ... of $17 million by Ascension Ventures , Cerner ... Funding. Series D funding closed on July 27, 2015, ... $60 million in three years. The new ... trajectory for Voalte. The privately held company grew revenue ...
(Date:9/1/2015)... BEDFORD, Mass. , Sept. 1, 2015  Shareholder ... whether certain officers and directors of ConforMIS, Inc. ... 1934.  ConforMIS is a medical technology company that uses ... sell joint replacement implants that are individually sized and ... View this press release on the law firm,s Shareholder ...
Breaking Medicine Technology:CytoSorbents to Present at the 2015 Rodman & Renshaw Annual Global Investment Conference 2CytoSorbents to Present at the 2015 Rodman & Renshaw Annual Global Investment Conference 3CytoSorbents to Present at the 2015 Rodman & Renshaw Annual Global Investment Conference 4Voalte Raises $17 Million in Series D Financing 2Voalte Raises $17 Million in Series D Financing 3Voalte Raises $17 Million in Series D Financing 4Robbins Arroyo LLP Is Investigating the Officers and Directors of ConforMIS, Inc. (CFMS) on Behalf of Shareholders 2
Cached News: